Clinical trial
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
NCT04500574 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
- Lead sponsor
- Massachusetts Eye and Ear Infirmary
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- April 3, 2024
- Completion date
- October 10, 2025
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.